SciSparc, a specialty pharmaceutical company, is working on drug clinical trials with applications for Tourette Syndrome, Obstructive Sleep Apnea, Alzheimer’s Disease and Agitation, Autism Spectrum Disorder, and two in pre-clinical studies for Status Epilepticus, and Chronic Pain. They just released news on their newest product that will be the first of its kind to treat Paine addiction which is a major problem in the U.S. with over 100,000 drug overdoses in 2021 alone. Learn more about the company at scisparc.com.